BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zelinkova Z, Bultman E, Vogelaar L, Bouziane C, Kuipers EJ, van der Woude CJ. Sex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease. World J Gastroenterol 2012; 18(47): 6967-6973 [PMID: 23322995 DOI: 10.3748/wjg.v18.i47.6967]
URL: https://www.wjgnet.com/1007-9327/full/v18/i47/6967.htm
Number Citing Articles
1
Yasmin Schmid, Alexander Navarini, Zita-Rose Manjaly Thomas, Bettina Pfleiderer, Stephan Krähenbühl, Simon M Mueller. Sex differences in the pharmacology of itch therapies—a narrative reviewCurrent Opinion in Pharmacology 2019; 46: 122 doi: 10.1016/j.coph.2019.05.008
2
André Farkouh, Christoph Baumgärtel, Roman Gottardi, Margit Hemetsberger, Martin Czejka, Alexandra Kautzky-Willer. Sex-Related Differences in Drugs with Anti-Inflammatory PropertiesJournal of Clinical Medicine 2021; 10(7): 1441 doi: 10.3390/jcm10071441
3
Ross M. Maltz, Pedro Marte-Ortiz, Madeline G. McClinchie, Miranda E. Hilt, Michael T. Bailey. T Cell-Induced Colitis Is Exacerbated by Prolonged Stress: A Comparison in Male and Female MiceBiomedicines 2024; 12(1): 214 doi: 10.3390/biomedicines12010214
4
Irina Blumenstein, Elena Sonnenberg. Sex- and gender-related differences in inflammatory bowel diseasesFrontiers in Gastroenterology 2023; 2 doi: 10.3389/fgstr.2023.1199687
5
Christine M. Madla, Francesca K.H. Gavins, Hamid A. Merchant, Mine Orlu, Sudaxshina Murdan, Abdul W. Basit. Let’s talk about sex: Differences in drug therapy in males and femalesAdvanced Drug Delivery Reviews 2021; 175: 113804 doi: 10.1016/j.addr.2021.05.014
6
Bruno Laganà, Angelo Zullo, Maria Lia Scribano, Maria Sole Chimenti, Alberto Migliore, Andrea Picchianti Diamanti, Roberto Lorenzetti, Palma Scolieri, Lorenzo Ridola, Elena Ortona, Marina Pierdominici, Vincenzo Bruzzese. Sex Differences in Response to TNF-Inhibiting Drugs in Patients With Spondyloarthropathies or Inflammatory Bowel DiseasesFrontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00047
7
Mitchell R. K. L. Lie, Joany E. Kreijne, C. Janneke van der Woude. Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohnʼs DiseaseInflammatory Bowel Diseases 2017; 23(1): 75 doi: 10.1097/MIB.0000000000000981
8
Elena Sonnenberg, Alica Kubesch-Grün. Gender-Medizin bei chronisch entzündlicher DarmerkrankungDie Gastroenterologie 2023; 18(6): 455 doi: 10.1007/s11377-023-00738-8
9
Kwi Suk Kim, Young Hee Choi, Aree Moon, Sang Geon Kim. Body Weight as a Determining Factor in the Predominance of Adverse Drug Reactions Induced by Fixed-Dose Adalimumab Injections in Female Patients in a Korean Hospital SettingJournal of Clinical Medicine 2020; 9(2): 461 doi: 10.3390/jcm9020461
10
Luis Fernández-Salazar, Fernando Muñoz, Jesús Barrio, Concepción Muñoz, Ramón Pajares, Montserrat Rivero, Vanessa Prieto, Jesús Legido, Abdel Bouhmidi, Maite Herranz, Nereida Fernández, Ramón Sánchez-Ocaña, Diana Joao, Fernando Santos. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study)Scandinavian Journal of Gastroenterology 2016; 51(2): 186 doi: 10.3109/00365521.2015.1070900
11
Bálint Tél, Bence Stubnya, Noémi Gede, Péter Varjú, Zoltán Kiss, Katalin Márta, Péter Jenő Hegyi, András Garami, Eszter Hegyi, Zsolt Szakács, Péter Hegyi, Gábor Veres. Inflammatory Bowel Diseases Elevate the Risk of Developing Acute PancreatitisPancreas 2020; 49(9): 1174 doi: 10.1097/MPA.0000000000001650
12
Rafael Mineiro, Cecília Santos, Isabel Gonçalves, Manuel Lemos, José Eduardo B. Cavaco, Telma Quintela. Regulation of ABC transporters by sex steroids may explain differences in drug resistance between sexesJournal of Physiology and Biochemistry 2023; 79(3): 467 doi: 10.1007/s13105-023-00957-1
13
Ciclosporin/steroidsReactions Weekly 2021; 1852(1): 129 doi: 10.1007/s40278-021-94582-8
14
Andrea Cignarella, Elisabetta Vegeto, Chiara Bolego, Luigia Trabace, Lucia Conti, Elena Ortona. Sex-oriented perspectives in immunopharmacologyPharmacological Research 2023; 197: 106956 doi: 10.1016/j.phrs.2023.106956
15
Johannes P.D. Schultheiss, Eelco C. Brand, Evert Lamers, Willemijn C.M. van den Berg, Fiona D.M. van Schaik, Bas Oldenburg, Herma H. Fidder. Earlier discontinuation of TNF‐α inhibitor therapy in female patients with inflammatory bowel disease is related to a greater risk of side effectsAlimentary Pharmacology & Therapeutics 2019; 50(4): 386 doi: 10.1111/apt.15380
16
Janka Bábíčková, Ľubomíra Tóthová, Eva Lengyelová, Anastázie Bartoňová, Július Hodosy, Roman Gardlík, Peter Celec. Sex Differences in Experimentally Induced Colitis in Mice: a Role for EstrogensInflammation 2015; 38(5): 1996 doi: 10.1007/s10753-015-0180-7
17
Victor K. Tso, Beate C. Sydora, Rae R. Foshaug, Thomas A. Churchill, Jason Doyle, Carolyn M. Slupsky, Richard N. Fedorak, Benoit Foligne. Metabolomic Profiles Are Gender, Disease and Time Specific in the Interleukin-10 Gene-Deficient Mouse Model of Inflammatory Bowel DiseasePLoS ONE 2013; 8(7): e67654 doi: 10.1371/journal.pone.0067654
18
Pablo Garrido-Gil, Ana I Rodriguez-Perez, Lucia Lage, Jose L Labandeira-Garcia, Rozalyn M Anderson. Estrogen Deficiency and Colonic Function: Surgical Menopause and Sex Differences in Angiotensin and Dopamine Receptor InteractionThe Journals of Gerontology: Series A 2021; 76(9): 1533 doi: 10.1093/gerona/glaa244
19
Jasmijn Z. Jagt, Koen W. Holleman, Marc A. Benninga, Johan E. Van Limbergen, Nanne K. H. de Boer, Tim G. J. de Meij. Effectiveness of strategies to suppress antibodies to infliximab in pediatric inflammatory bowel diseaseJournal of Pediatric Gastroenterology and Nutrition 2024; 78(1): 57 doi: 10.1002/jpn3.12041
20
I. Blumenstein, B. Siegmund, E. Sonnenberg. Geschlechtsspezifische Unterschiede bei chronisch-entzündlichen DarmerkrankungenDer Gastroenterologe 2019; 14(2): 102 doi: 10.1007/s11377-019-0323-8
21
Mitchell R. K. L. Lie, Emma Paulides, C. Janneke van der Woude. Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse eventsInternational Journal of Colorectal Disease 2020; 35(8): 1489 doi: 10.1007/s00384-020-03663-2
22
Carole L. Galligan, Eleanor N. Fish. Sex and Gender Differences in Infection and Treatments for Infectious Diseases2015; : 1 doi: 10.1007/978-3-319-16438-0_1
23
Yue Yu, Jun Chen, Dingcheng Li, Liwei Wang, Wei Wang, Hongfang Liu. Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug EventsScientific Reports 2016; 6(1) doi: 10.1038/srep24955
24
Patricia Louis, Brian Mercer, Aiko M. Cirone, Christina Brust, Zachary J. Lee, Nwadiuto Esiobu, Zhongwei Li, Jianning Wei, C. Kathleen Dorey, Yoshimi Shibata, Changlong Nan, George S. Deepe. Dietary Chitin Particles Called Mimetic Fungi Ameliorate Colitis in Toll-Like Receptor 2/CD14- and Sex-Dependent MannersInfection and Immunity 2019; 87(5) doi: 10.1128/IAI.00006-19
25
Helen R. Gosselt, Jette A. van Lint, Leanne J. Kosse, Phyllis I. Spuls, Harald E. Vonkeman, Sander W. Tas, Frank Hoentjen, Michael T. Nurmohamed, Bart J.F. van den Bemt, Martijn B.A. van Doorn, Naomi T. Jessurun. Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseasesExpert Opinion on Drug Safety 2023; 22(6): 501 doi: 10.1080/14740338.2023.2181340